Efforts to advance anesthesia procedures are currently underway, with scientists striving to perfect patient safety while reducing unwanted side effects. Among such developments is a closed-loop anesthesia delivery system incorporating brain state monitoring for optimized drug administration. Through significant advancements made by researchers at The Picower Institute for Learning and Memory at MIT and Massachusetts General Hospital (MGH), this pioneering technology may help decrease post-operative cognitive side effects, especially in susceptible populations like the elderly.
This closed-loop anesthesia delivery system automates propofol doses every 20 seconds depending on brain state monitoring, as documented in a paper published in the journal PNAS Nexus. More accurate unconsciousness control is achieved through this, likely reducing the necessary anesthetic drug quantity and limiting potential negative effects. While not the first system of its kind, the technology's precision and customization capabilities certainly push the envelope ahead in the field.
Compared to off-the-shelf closed-loop anesthesia delivery systems, which largely mandate a uniform infusion rate grounded on basic patient characteristics like weight, height, and age, or operate under a proprietary "black box" control system, the new MIT and MGH system, labeled the Brain Arousal State Control Innovation Center (BASCIC), promises a more nuanced approach. Employing a physiologically principled unconsciousness readout obtained from local field potentials (LFPs), it can provide precise control over anesthesia dosage.
As revealed in animal testing, the BASCIC system, over nine anesthesia sessions, was able to control consciousness finely for over 18 hours straight. However, the researchers note there is still work left before this technology can be fit for human use. For instance, it will need to adapt to electroencephalograms (EEGs) measured through the scalp and establish a marker of unconsciousness grounded on human brain rhythms to transition smoothly to clinical applications.
Joining leaps in the understanding of anesthesia and its intricacies is a study by scientists at Columbia University published in the journal Neuron. This 2022 study discovered that general anesthesia may instigate the release of stress hormones, thereby escalating the risk of complications. These findings have catalyzed a push for a more accurate understanding and administration of anesthesia to manage such adverse outcomes.
A precarious balance, anesthesia presents risk in both over-dosing and under-dosing. In elderly patients, a constant propofol infusion rate can induce "burst suppression," a state of extreme unconsciousness linked to post-operative cognitive disorders. The BASCIC system's ability to maintain the desired unconsciousness level automatically brings forth a potential change in anesthesia management, with possible marked improvement in patient care.
Technology's imprint on anesthesia has been profoundly beneficial, with advancements such as microneedles and nanoparticles paving the way for less invasive, targeted anesthesia, and real-time ultrasound aiding regional anesthesia. Such systems, like BASCIC, might help reduce complications, enhance patient outcomes, and considerably improve anesthesia care.
Despite promising prospects, extensive work is required to confirm the safety and efficacy of these emerging developments before they can be used clinically. While the BASCIC researchers are hopeful about extending their system to humans, extensive testing and setting reliable benchmarks are integral to ensuring patient welfare and positive outcomes for all involved.
